Skip to NavigationSkip to content

News

0
Celgene took a gamble when it spent $710 million up-front on an inflammatory disorder treatment, but it now looks likely to have been an expensive...
0
A new report published in The Lancet has revealed that all forms of pollution are linked with 9 million deaths worldwide in 2015 alone. Air pollution...
0
Giliad's Yesarta becomes second FDA-approved CAR T treatment and AstraZeneca admits efficacy data for an acquired cancer drug was fabricated. Check...
0
Research from scientists at the Wellcome Trust Sanger Institute has found that only between one and 10 genetic mutations are the driver behind many...

Features

Peter Naredi, of ECCO, explores how a multi-dimensional approach is necessary to ensure that patients receive access to the most important medical...